What is Minual Residual Disease (MRD) and how it can be monitored?

New trends in Multiple Myeloma management is to look for the few amounts of cancer cells that might remain in your bone marrow. These residual cells are responsible of the disease relapse. Myeloma Patients Europe will hold an online webinar on Minimal Residual Disease (MRD) that will highlight the importance of this monitoring method and will detail new highly sensitive techniques used to investigate it.